The time has come to target connective tissue growth factor in diabetic complications.
Twigg
S M
SM
Discipline of Medicine, University of Sydney, New South Wales 2006, Australia. stwigg@med.usyd.edu.au
Cooper
M E
ME
D000818:Animals; D001315:Australia; D055513:Connective Tissue Growth Factor; D048909:Diabetes Complications / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000139:chemically induced / Q000378:metabolism; D006801:Humans; D017874:Immediate-Early Proteins / Q000009:adverse effects* / Q000502:physiology; D036341:Intercellular Signaling Peptides and Proteins / Q000009:adverse effects* / Q000502:physiology; D008722:Methods; D008954:Models, Biological
C526317:CCN2 protein, human; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D055513:Connective Tissue Growth Factor